Cargando…
MBCL-26. FACTORS ASSOCIATED WITH LONGER SURVIVAL AFTER FIRST RECURRENCE IN MEDULLOBLASTOMA BY MOLECULAR SUBGROUP AFTER RISK-BASED INITIAL THERAPY
OBJECTIVE: To evaluate differences in time to recurrence among molecular subgroups of medulloblastoma treated on a single protocol and to identify factors associated with survival after first recurrence. METHODS: Time to recurrence following SJMB03 treatment was compared across methylation subgroups...
Autores principales: | Chintagumpala, Murali, Terhune, Colton, Tong, Lin, Bouffet, Eric, Bartels, Ute, Fisher, Michael, Hassall, Tim, Gururangan, Shridharan, Schroeder, Kristin, Hansford, Jordan, Quang, Dong Anh Khuong, Cohn, Richard, Kellie, Stewart, McCowage, Geoffrey, Smith, Kyle, Northcott, Paul, Robinson, Giles, Gajjar, Amar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715800/ http://dx.doi.org/10.1093/neuonc/noaa222.502 |
Ejemplares similares
-
MBRS-20. CSF-DERIVED CIRCULATING TUMOR DNA AS A BIOMARKER FOR DISEASE PROGRESSION AND TUMOR EVOLUTION IN MEDULLOBLASTOMA
por: Liu, Anthony Pak-Yin, et al.
Publicado: (2020) -
MBCL-08. INTEGRATIVE MOLECULAR ANALYSIS OF PATIENT-MATCHED DIAGNOSTIC AND RELAPSED MEDULLOBLASTOMAS
por: Kumar, Rahul, et al.
Publicado: (2020) -
MEDB-74. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
por: Northcott, Paul, et al.
Publicado: (2022) -
MBCL-52. ENDOCRINE PROFILE AFTER MEDULLOBLASTOMA TREATMENT
por: Pavon-Mengual, Miriam, et al.
Publicado: (2020) -
MBCL-21. GERMLINE ELONGATOR MUTATIONS IN SONIC HEDGEHOG MEDULLOBLASTOMA
por: Robinson, Giles W, et al.
Publicado: (2020)